Interestingly, among pediatric patients harboring an SDHB mutation, sweating was significantly associated with earlier development of metastatic disease (p = 0.0073), and for those without metastases at initial diagnosis, patients with tumor pain developed metastases at an earlier interval than those without tumor pain (p = 0.0088) (23). Here, SDHB is linked to metastatic neoplasm.